Home » Watson Pays $27 Million to Exit Drug Inflation MDL
Watson Pays $27 Million to Exit Drug Inflation MDL
Watson Pharmaceuticals agreed to pay $27 million to settle the remaining whistleblower claims against it in the Massachusetts multidistrict litigation accusing several pharmaceutical companies of reporting inflated drug prices to Medicaid.
Law360
Law360
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May